Samer Srour, MB, ChB, MS, is an accomplished physician-scientist who currently serves as an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas. He is a leading expert in the field of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), with a particular focus on developing novel therapies for these diseases.

Dr. Srour completed his medical training at the American University of Beirut in Lebanon and subsequently pursued a residency in internal medicine at Indiana University. He then completed a fellowship in hematology/oncology at the University of Texas Southwestern Medical Center, where he also obtained his PhD in cell biology.

Throughout his career, Dr. Srour has received numerous awards and honors for his research accomplishments, including the Leukemia and Lymphoma Society's Career Development Award and the American Society of Hematology's Scholar Award. He has authored over 80 peer-reviewed publications and has been invited to speak at numerous national and international conferences.

Dr. Srour's research focuses on understanding the genetic and epigenetic alterations that drive the development and progression of AML and MDS. He is particularly interested in developing new targeted therapies that can effectively treat these diseases while minimizing toxicity to normal cells. His research has led to the identification of several novel therapeutic targets, and his work is currently being translated into clinical trials.

In addition to his research activities, Dr. Srour is a committed mentor and educator. He has mentored numerous students and trainees, many of whom have gone on to successful careers in academic medicine. He is also actively involved in teaching and has developed several educational programs on the diagnosis and management of AML and MDS.

Overall, Dr. Srour is a highly respected physician-scientist who has made significant contributions to the field of hematology/oncology. His dedication to improving the lives of patients with AML and MDS is reflected in his innovative research, his commitment to mentoring the next generation of scientists, and his unwavering focus on improving patient outcomes.